These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6172236)
1. Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446. Mendelsohn FA; Csicsmann J; Hutchinson JS Clin Sci (Lond); 1981 Dec; 61 Suppl 7():277s-280s. PubMed ID: 6172236 [TBL] [Abstract][Full Text] [Related]
2. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats. Takata Y; Di Nicolantonio R; Hutchinson JS Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421. Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563 [No Abstract] [Full Text] [Related]
4. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme. DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478 [TBL] [Abstract][Full Text] [Related]
5. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension]. Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607 [No Abstract] [Full Text] [Related]
6. Kinetics of captopril- and enalapril-induced inhibition of pulmonary angiotensin converting enzyme in vivo. Moalli R; Howell RE; Gillis CN J Pharmacol Exp Ther; 1985 Aug; 234(2):372-7. PubMed ID: 2991497 [TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine. Saruta T; Suzuki H; Okuno T; Kondo K Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid. Reynolds CH Biochem Pharmacol; 1984 Apr; 33(8):1273-6. PubMed ID: 6324821 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system. Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635 [No Abstract] [Full Text] [Related]
10. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats. Komori T; Takada T; Funae Y; Yamamoto K Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787 [No Abstract] [Full Text] [Related]
11. Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney. Ogihara T; Yoshizawa M; Yasui T; Nakane H; Nakane Y; Saruta T Jpn Heart J; 1983 Nov; 24(6):975-83. PubMed ID: 6323782 [TBL] [Abstract][Full Text] [Related]
12. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats. Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184 [TBL] [Abstract][Full Text] [Related]
13. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat. Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815 [TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats. Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402 [TBL] [Abstract][Full Text] [Related]
15. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline. Bull HG; Thornberry NA; Cordes MH; Patchett AA; Cordes EH J Biol Chem; 1985 Mar; 260(5):2952-62. PubMed ID: 2982845 [TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril. Okuda M; Arakawa K J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo. Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454 [TBL] [Abstract][Full Text] [Related]
19. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446). Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764 [TBL] [Abstract][Full Text] [Related]
20. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]